Mechanism of Action of Ivabradine

Introduction

Ivabradine is a selective heart rate–reducing agent primarily used in the management of chronic stable angina and heart failure with reduced ejection fraction (HFrEF). Unlike beta-blockers, it reduces heart rate without affecting myocardial contractility or blood pressure significantly. Its action is highly specific to the sinoatrial (SA) node.


MOA of Ivabradine
Mechanism of action of Ivabradine
Mechanism of Action of Ivabradine Flowchart
Flowchart of mechanism of action of Ivabradine
Mechanism of action of Ivabradine
Ivabradine pharmacology

Mechanism of Action (Step-wise)

  1. Selective Inhibition of If (“Funny”) Current
    Ivabradine selectively inhibits the If current in the sinoatrial (SA) node.
  2. Blockade of HCN Channels
    The If current is mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Ivabradine blocks these channels.
  3. Reduction in Pacemaker Activity
    Inhibition of If current slows spontaneous diastolic depolarization in SA node cells.
  4. Decrease in Heart Rate
    Slower depolarization reduces the firing rate of the SA node, leading to decreased heart rate (negative chronotropic effect).
  5. Prolongation of Diastole
    Reduced heart rate increases diastolic duration, improving coronary perfusion.
  6. No Effect on Contractility or Conduction
    Ivabradine does not significantly affect myocardial contractility (inotropy) or atrioventricular conduction.

Pharmacokinetics

  • Administration: Oral
  • Absorption: Good oral absorption
  • Bioavailability: ~40% (first-pass metabolism)
  • Metabolism: Hepatic via CYP3A4
  • Half-life: ~6 hours
  • Excretion: Fecal and renal

Clinical Uses

  • Chronic stable angina (in patients intolerant to beta-blockers)
  • Heart failure with reduced ejection fraction (HFrEF)
  • Heart rate control in sinus rhythm

Adverse Effects

  • Bradycardia
  • Luminous phenomena (phosphenes)
  • Atrial fibrillation
  • Headache
  • Dizziness

Comparative Analysis

FeatureIvabradinePropranololDiltiazem
ClassIf channel inhibitorβ-blockerCalcium channel blocker
MechanismBlocks SA node If currentβ1 blockadeL-type Ca²⁺ channel blockade
Effect on HR↓↓↓↓
Effect on contractilityNo significant effectDecreasesDecreases
Effect on BPMinimalDecreasesDecreases
UseHF, anginaHTN, anginaHTN, arrhythmias

Ivabradine provides a unique advantage by selectively reducing heart rate without affecting blood pressure or myocardial contractility. This makes it especially useful in patients who cannot tolerate beta-blockers.


MCQs

  1. Ivabradine inhibits which current?
    a) Na⁺ current
    b) Ca²⁺ current
    c) If current
    d) K⁺ current
    Answer: c) If current
  2. Site of action of ivabradine:
    a) AV node
    b) SA node
    c) Ventricles
    d) Purkinje fibers
    Answer: b) SA node
  3. Ivabradine acts on which channels?
    a) Voltage-gated Na⁺ channels
    b) HCN channels
    c) L-type Ca²⁺ channels
    d) K⁺ channels
    Answer: b) HCN channels
  4. Main clinical effect:
    a) Increased BP
    b) Reduced heart rate
    c) Increased contractility
    d) Vasoconstriction
    Answer: b) Reduced heart rate
  5. Ivabradine does NOT affect:
    a) Heart rate
    b) SA node activity
    c) Contractility
    d) Pacemaker activity
    Answer: c) Contractility
  6. Unique side effect:
    a) Dry mouth
    b) Phosphenes
    c) Constipation
    d) Rash
    Answer: b) Phosphenes
  7. Metabolism occurs via:
    a) CYP2D6
    b) CYP3A4
    c) MAO
    d) COMT
    Answer: b) CYP3A4
  8. Used in:
    a) Hypertension
    b) Heart failure
    c) Diabetes
    d) Asthma
    Answer: b) Heart failure
  9. Ivabradine prolongs:
    a) Systole
    b) Diastole
    c) QT interval
    d) PR interval
    Answer: b) Diastole
  10. Compared to beta-blockers, ivabradine:
    a) Decreases BP more
    b) Has no cardiac effect
    c) Does not affect contractility
    d) Causes vasoconstriction
    Answer: c) Does not affect contractility

FAQs

  1. What is the mechanism of action of ivabradine?
    It selectively inhibits the If current in the SA node, reducing heart rate.
  2. What makes ivabradine different from beta-blockers?
    It lowers heart rate without affecting contractility or blood pressure.
  3. What is the If current?
    A pacemaker current responsible for spontaneous depolarization in SA node cells.
  4. Why does ivabradine cause visual disturbances?
    Due to effects on retinal HCN channels.
  5. In which patients is ivabradine preferred?
    Patients with heart failure who cannot tolerate beta-blockers.
  6. Does ivabradine affect blood pressure?
    No, it has minimal effect on blood pressure.

References

Author

  • Harsh Singh Rajput

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators